Microsoft's CEO, Satya Nadella, has announced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding ...

Centella AI streamlines drug discovery using AI-powered platforms, reducing R&D time and cost with real-world scientific validation ...

Understanding protein motion is essential to understanding biology and advancing drug discovery,” said Nadella, in a post on ...

Microsoft's BioEmu, an AI-driven model, decodes protein motion to enhance drug discovery, offering rapid insights into protein structures and functions.

Revolution Medicines' proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand ...

The start-up, which aims to raise tens of millions of US dollars in an angel funding round, hopes to compete globally, ...

Microsoft’s new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya ...

Drug discovery startup Synfini Inc. said today it has closed on an $8.9 million expansion funding round led by JSL Health ...

Researchers discovered how to flip the structure of complex drug compounds using a simple reagent, offering a game-changing ...

Revolution Medicines has zeroed in on Iambic Therapeutics’ AI drug discovery platform, striking a multi-year technology and research collaboration that gives Iambic the chance to earn up to $25 mil | ...

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions ...